Migraine, Migraine Disorders
Conditions
Keywords
Migraine
Brief summary
Clinical study participation has historically been heavily biased toward specific demographics. This study will invite several participants to gather a wide range of information on clinical trial experiences for migraine patients. The aim of the study is to identify the factors that limit the ability of a person to enroll in, as well as complete a clinical trial for treatment of migraine. People with migraine who are invited to take part in medical research will benefit from the analysis of the data.
Interventions
None listed
Sponsors
Power Life Sciences Inc.
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Patient is a minimum of 18 years of age * Patient has been diagnosed with a type of migraine * Patient plans to participate in an interventional clinical trial for the condition of migraine * Patient has access to a home internet connection in order to provide regular updates through the course of the study
Exclusion criteria
* Patient has an ECOG score of 4 or higher * Patient is not able to provide consistent digital updates as per study requirements * Patient does not complete or agree to terms outlined in the Informed Consent Form
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of patients who decide to enroll in a migraine clinical trial | 3 months |
| Rate of patients who remain in migraine clinical trial to trial completion | 12 months |
Contacts
Primary ContactMichael B Gill
Outcome results
None listed